Publication | Closed Access

The Percent of Positive Biopsy Cores Improves Prediction of Prostate Cancer–Specific Death in Patients Treated With Dose-Escalated Radiotherapy

Positive Biopsy CoresRadiation MedicineNuclear MedicineProstate Cancer–specific DeathMedicineDose-escalated RadiotherapyCancer PrognosisRadiation Therapy PlanningProstatic DiseaseOncologyRadiation OncologyTreatment VerificationRadiologyHealth Sciences